Advertisement #1
Home Clinical development

Clinical development

Clinical Development

A Multicomponent Biomarker Approach Will Shift Cancer Care

Ofer Sharon, MD, MBA -

Reducing Reliance on Blood Transfusions for People With Lower-risk Myelodysplastic Syndromes

Editorial Team -

Dostarlimab + Chemotherapy Accepted for dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer

Editorial Team -

Radiation after Chemoimmunotherapy for Primary Mediastinal B-cell Lymphoma may Not be Necessary

Editorial Team -

Ciltacabtagene Autoleucel Reduces Risk of Progression of Multiple Myeloma after Lenalidomide

Editorial Team -

Trastuzumab Deruxtecan Is an Effective Option for Difficult-to-treat HER2-expressing Solid Tumors

Editorial Team -

Mirvetuximab Soravtansine Improves Survival in Women With Recurrent Ovarian Cancer

Editorial Team -

Study Shows Nivolumab Reduces Risk of Disease Progression in Advanced, Untreated Hodgkin Lymphoma

Editorial Team -

Adjuvant Osimertinib Significantly Improves Survival in Patients With Resected EGFR-Mutated NSCLC

Editorial Team -

Radiation Can Be Safely Omitted in Select Patients With Locally Advanced Rectal Cancer

Editorial Team -
123...29Page 1 of 29

LATEST NEWS

Advertisment #12
© 2001 - 2023 Sunvalley Communication, LLC. All Rights Reserved.

X